FTORAFUR

Ftorafur (tegafur) is a prodrug of 5FU inhibiting DNA synthesis in cancer cells. Side effects include myelosuppression, nausea, and fatigue. Only GMP materials will be supplied, logistics all according to GDP.

SKU: d5a3e4c55236 Category: Tag:

Product Description


Mechanism of Action

Ftorafur (tegafur) is a prodrug of 5fluorouracil that undergoes CYPmediated activation, gradually releasing 5FU to inhibit thymidylate synthase and RNA/DNA synthesis.

Benefits and Advantages

Used in prodrugactivation studies, oncologic cytotoxicity assays, TSinhibition modelling and combinationtherapy research.

Side Effects and Risks

Myelosuppression, GI toxicity, neurotoxicity and dermatologic reactions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C8H9FN2O3

Molecular Weight

200.17 g/mol

CAS Number

17902-23-7

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Partly miscible

Purity

Purity information is available upon request (COA).

Synonym

tegafur; 17902-23-7; Ftorafur; Futraful; Sinoflurol

IUPAC/Chemical Name

5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione

InChl Key

WFWLQNSHRPWKFK-UHFFFAOYSA-N

InChl Code

InChI=1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13)

References

https://pubchem.ncbi.nlm.nih.gov/compound/5386;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download